✦ LIBER ✦

A double-blind, placebo-controlled study with oxiracetam in demented patients administered the Luria-Nebraska Neuropsychological Battery

✍ Scribed by A. Mangoni; C. Perin; S. Smirne; I. Piccolo; F. De Filippi; C. Marchetti; A. Motta; G. C. Monza

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 313 KB
Volume: 14
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.430140311

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of oxiracetam (ISF 2522) in

The effects of oxiracetam (ISF 2522) in patients with organic brain syndrome (a double-blind controlled study with piracetam)

✍ Turan M. Itil; Gopi N. Menon; Mahir Bozak; Ayhan Songar 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 924 KB

A multicentre double-blind placebo-contr

A multicentre double-blind placebo-controlled study investigating the anxiolytic efficacy of hydroxyzine in patients with generalized anxiety

✍ T. Darcis; M. Ferreri; J. Natens; B. Burtin; P. Deram 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

The efficacy of hydroxyzine was investigated in 110 patients suffering from generalized anxiety, in a double-blind placebo controlled multicentre study. Oral hydroxyzine 50mg/day for four weeks significantly improved standard measurements of anxiety compared with placebo control. These improvements

Octreotide inhibits the meal-induced inc

Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: A double-blind, placebo-controlled study

✍ P. Aiden McCormick; Maria Rosa Biagini; Robert Dick; Lynda Greenslade; Jason Chi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 745 KB

In recent years many studies have suggested that somatostatin may be useful in the treatment of patients with bleeding esophageal varices, although there is still some controversy on this point (1-5). The mechanisms through which somatostatin exerts its beneficial therapeutic effects in patients wit

Ciprofloxacin or metronidazole for the t

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled pilot study

✍ Kelvin T. Thia; Uma Mahadevan; Brian G. Feagan; Cindy Wong; Alan Cockeram; Alain 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with

S-Adenosyl-L-methionine in the treatment

S-Adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: A randomized, double-blind, placebo-controlled study with negative results

✍ Dr. Jose Ribalta; Humberto Reyes; Manuel C. Gonzalez; Joaquin Iglesias; Marco Ar 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

S-Adenosyl-L-methionine has been reported to induce beneficial effects in intrahepatic cholestasis of pregnancy. Because cholestasis of pregnancy has a high prevalence in Chile and a deleterious effect on fetal prognosis, we decided to verify the efficacy of S-adenosyl-L-methionine in this disease.

LJP 394 for the prevention of renal flar

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study

✍ Donato Alarcón-Segovia; James A. Tumlin; Richard A. Furie; James D. McKay; Mario 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 2 views

## Abstract ## Objective To determine whether LJP 394 delays or prevents renal flare in patients with systemic lupus erythematosus (SLE) and a history of renal disease. ## Methods In a 76‐week, double‐blind, placebo‐controlled study, 230 SLE patients were randomized to receive 16 weekly doses of